Bank of Montreal’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.2M | Sell |
62,580
-220
| -0.4% | -$33.8K | ﹤0.01% | 1085 |
|
|
2025
Q4 | $10.9M | Sell |
62,800
-28,966
| -32% | -$5.29M | ﹤0.01% | 1087 |
|
|
2025
Q3 | $13.2M | Buy |
91,766
+62,081
| +209% | +$7.61M | 0.01% | 933 |
|
|
2025
Q2 | $2.99M | Sell |
29,685
-721
| -2% | -$55.1K | ﹤0.01% | 1440 |
|
|
2025
Q1 | $2.32M | Sell |
30,406
-7,347
| -19% | -$562K | ﹤0.01% | 1449 |
|
|
2024
Q4 | $2.61M | Sell |
37,753
-225,115
| -86% | -$16.2M | ﹤0.01% | 1453 |
|
|
2024
Q3 | $19.1M | Buy |
+262,868
| New | +$19.4M | 0.01% | 804 |
|
|
2024
Q2 | – | Sell |
-592
| Closed | -$16.1K | – | 4053 |
|
|
2024
Q1 | $16.1K | Buy |
+592
| New | +$16.6K | ﹤0.01% | 3636 |
|
|
2022
Q3 | – | Sell |
-468
| Closed | -$10 | – | 4228 |
|
|
2022
Q2 | $10 | Buy |
+468
| New | +$9.81K | ﹤0.01% | 3854 |
|
|
2021
Q3 | – | Sell |
-84,694
| Closed | -$2.52M | – | 3878 |
|
|
2021
Q2 | $2.52M | Buy |
84,694
+80,272
| +1,815% | +$2.38M | ﹤0.01% | 1938 |
|
|
2021
Q1 | $143K | Sell |
4,422
-11,661
| -73% | -$446K | ﹤0.01% | 3242 |
|
|
2020
Q4 | $534K | Buy |
16,083
+10,650
| +196% | +$389K | ﹤0.01% | 2662 |
|
|
2020
Q3 | $179K | Sell |
5,433
-3,524
| -39% | -$101K | ﹤0.01% | 2786 |
|
|
2020
Q2 | $250K | Buy |
8,957
+7,553
| +538% | +$179K | ﹤0.01% | 2616 |
|
|
2020
Q1 | $21K | Sell |
1,404
-26,791
| -95% | -$635K | ﹤0.01% | 3227 |
|
|
2019
Q4 | $673K | Buy |
28,195
+5,700
| +25% | +$116K | ﹤0.01% | 2498 |
|
|
2019
Q3 | $397K | Buy |
22,495
+15,177
| +207% | +$293K | ﹤0.01% | 2531 |
|
|
2019
Q2 | $187K | Buy |
7,318
+6,634
| +970% | +$185K | ﹤0.01% | 2961 |
|
|
2019
Q1 | $20K | Sell |
684
-1,175
| -63% | -$30.5K | ﹤0.01% | 3673 |
|
|
2018
Q4 | $24K | Buy |
1,859
+646
| +53% | +$10.3K | ﹤0.01% | 3578 |
|
|
2018
Q3 | $25K | Sell |
1,213
-82
| -6% | -$1.85K | ﹤0.01% | 3635 |
|
|
2018
Q2 | $31K | Buy |
1,295
+611
| +89% | +$15.7K | ﹤0.01% | 3598 |
|
|
2018
Q1 | $15K | Sell |
684
-268
| -28% | -$7.05K | ﹤0.01% | 3641 |
|
|
2017
Q4 | $30K | Sell |
952
-6
| -0.6% | -$177 | ﹤0.01% | 3455 |
|
|
2017
Q3 | $30K | Buy |
958
+299
| +45% | +$5.7K | ﹤0.01% | 3394 |
|
|
2017
Q2 | $11K | Hold |
659
| – | – | ﹤0.01% | 3693 |
|
|
2017
Q1 | $12K | Buy |
659
+298
| +83% | +$4.59K | ﹤0.01% | 3498 |
|
|
2016
Q4 | $5K | Sell |
361
-806
| -69% | -$11K | ﹤0.01% | 3741 |
|
|
2016
Q3 | $17K | Sell |
1,167
-2,332
| -67% | -$29.2K | ﹤0.01% | 3403 |
|
|
2016
Q2 | $35K | Buy |
3,499
+1,700
| +94% | +$19.8K | ﹤0.01% | 3174 |
|
|
2016
Q1 | $23K | Sell |
1,799
-2,333
| -56% | -$30.7K | ﹤0.01% | 3352 |
|
|
2015
Q4 | $75K | Hold |
4,132
| – | – | ﹤0.01% | 2887 |
|
|
2015
Q3 | $77K | Buy |
4,132
+633
| +18% | +$15.8K | ﹤0.01% | 2743 |
|
|
2015
Q2 | $85K | Hold |
3,499
| – | – | ﹤0.01% | 2813 |
|
|
2015
Q1 | $73K | Buy |
+3,499
| New | +$61.6K | ﹤0.01% | 2775 |
|
|
2014
Q3 | – | Sell |
-880
| Closed | -$18K | – | 4200 |
|
|
2014
Q2 | $18K | Sell |
880
-8,575
| -91% | -$127K | ﹤0.01% | 3637 |
|
|
2014
Q1 | $180K | Buy |
+9,455
| New | +$180K | ﹤0.01% | 2542 |
|
Other funds holding INSM
DGM
VPM
VCM
BBA
Bank of Montreal's INSM Position: Q1 2026 in Review
Bank of Montreal reduced its Insmed (INSM) stake by 0.35% in Q1 2026, selling an estimated $33.8K and leaving 62,580 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1085.
Bank of Montreal first reported a position in INSM in Q1 2014 and has held it in 37 quarters since. The position peaked at $19.1M in Q3 2024. 673 funds tracked by Wall St. Rank hold INSM as of Q1 2026.
- Bank of Montreal held 62,580 shares of Insmed worth $10.2M as of Q1 2026.
- Bank of Montreal sold 220 Insmed shares in Q1 2026, an estimated $33.8K.
- Insmed made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #1085 holding.
- Bank of Montreal first reported a position in Insmed in Q1 2014 and has held it in 37 quarters since.
- Bank of Montreal's Insmed position peaked at $19.1M in Q3 2024.
- 673 funds tracked by Wall St. Rank held Insmed as of Q1 2026.
Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.